Detalles de la búsqueda
1.
Lenalidomide plus rituximab for the initial treatment of frail older patients with DLBCL: the FIL_ReRi phase 2 study.
Blood
; 142(17): 1438-1447, 2023 10 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-37418685
2.
Impact of immunochemotherapy with R-bendamustine or R-CHOP for treatment naïve advanced-stage follicular lymphoma: A subset analysis of the FOLL12 trial by Fondazione Italiana Linfomi.
Hematol Oncol
; 41(4): 655-662, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-37246287
3.
New clinical application of indocyanine green in fluorescence-guided laparoscopic lymph-node biopsy in case of lymphoma. Preliminary results on a case series.
BMC Surg
; 23(1): 264, 2023 Sep 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37658333
4.
Pre-transplant minimal residual disease assessment and transplant-related factors predict the outcome of acute myeloid leukemia patients undergoing allogeneic stem cell transplantation.
Eur J Haematol
; 107(5): 573-582, 2021 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-34297437
5.
Lenalidomide in Pretreated Mantle Cell Lymphoma Patients: An Italian Observational Multicenter Retrospective Study in Daily Clinical Practice (the Lenamant Study).
Oncologist
; 23(9): 1033-1038, 2018 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-29674440
6.
Performance of serum (1,3)-ß-d-glucan screening for the diagnosis of invasive aspergillosis in neutropenic patients with haematological malignancies.
Mycoses
; 61(9): 650-655, 2018 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-29693758
7.
Good tolerability of high dose colistin-based therapy in patients with haematological malignancies.
Infection
; 45(4): 505-511, 2017 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-28353153
8.
High feasibility and antileukemic efficacy of fludarabine, cytarabine, and idarubicin (FLAI) induction followed by risk-oriented consolidation: A critical review of a 10-year, single-center experience in younger, non M3 AML patients.
Am J Hematol
; 91(8): 755-62, 2016 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-27084986
9.
Longitudinal minimal residual disease (MRD) evaluation in acute myeloid leukaemia with NPM1 mutation: from definition of molecular relapse to MRD-driven salvage approach.
Br J Haematol
; 186(6): e223-e225, 2019 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-31348524
10.
Early minimal residual disease assessment after AML induction with fludarabine, cytarabine and idarubicin (FLAI) provides the most useful prognostic information.
Br J Haematol
; 184(3): 457-460, 2019 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-29359798
11.
Liposomal daunorubicin, fludarabine, and cytarabine (FLAD) as bridge therapy to stem cell transplant in relapsed and refractory acute leukemia.
Ann Hematol
; 93(12): 2011-8, 2014 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-24989345
12.
Unmanipulated haploidentical bone marrow transplantation and posttransplantation cyclophosphamide for hematologic malignancies after myeloablative conditioning.
Biol Blood Marrow Transplant
; 19(1): 117-22, 2013 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-22940057
13.
Bortezomib as salvage treatment for heavily pretreated relapsed lymphoma patients: a multicenter retrospective study.
Hematol Oncol
; 31(4): 179-82, 2013 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-23108928
14.
Prompt detection of L-asparaginase inactivation is crucial to optimize treatment efficacy also in aggressive lymphomas.
Hematol Oncol
; 36(2): 498-499, 2018 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-29052244
15.
De novo AML patients with favourable-intermediate karyotype may benefit from the addition of low-dose gemtuzumab ozogamicin (GO) to fludarabine, Ara-C and idarubicin (FLAI): a contribution to the reopened "GO question".
Ann Hematol
; 92(10): 1309-18, 2013 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-23686116
16.
A blastic plasmacytoid dendritic cell neoplasm-like phenotype identifies a subgroup of npm1-mutated acute myeloid leukemia patients with worse prognosis.
Am J Hematol
; 93(2): E33-E35, 2018 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-29080220
17.
Divergent Oxidative Stress in Normal Tissues and Inflammatory Cells in Hodgkin and Non-Hodgkin Lymphoma.
Cancers (Basel)
; 15(13)2023 Jul 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37444643
18.
Candidate germline biomarkers of lenalidomide efficacy in mantle cell lymphoma: the Fondazione Italiana Linfomi MCL0208 trial.
Blood Adv
; 7(14): 3764-3774, 2023 07 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-37058477
19.
Romidepsin-CHOEP followed by high-dose chemotherapy and stem-cell transplantation in untreated Peripheral T-Cell Lymphoma: results of the PTCL13 phase Ib/II study.
Leukemia
; 37(2): 433-440, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36653509
20.
Combining flow cytometry and WT1 assessment improves the prognostic value of pre-transplant minimal residual disease in acute myeloid leukemia.
Haematologica
; 102(9): e348-e351, 2017 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-28495917